Article Information
History
- May 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Wonjun Ji, MD, Ph.D1,¶,
- Kyungmin Huh, MD2,¶,
- Minsun Kang, MHS3,
- Jinwook Hong, MSF3,
- Gi Hwan Bae, MSC3,
- Rugyeom Lee, MPH3,
- Yewon Na, MPH3,
- Mr. Hyoseon Choi, Ms.4,
- Seon Yeong Gong4,
- Yoon-Hyeong Choi, PhD4,
- Kwang-Pil Ko, MD, PhD4,
- Jeong-Soo Im, MD., PhD4 and
- Jaehun Jung, MD, PhD3,4,*
- 1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- 2Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 3Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- 4Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea
- ↵*Correspondence to Jaehun Jung, MD, PhD
, Department of Preventive Medicine, Gachon University College of Medicine, 38-13, Dokjeom-ro 3, Incheon, Korea, E-mail: eastside1st{at}gmail.com, Phone: +82-10-6359-3201
↵¶ Wonjun Ji, Kyungmin Huh, and Minsun Kang¶ contributed equally to this work.
Posted May 11, 2020.
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea
